Molecular and cellular mechanisms of action of cannabidiol

N Martinez Naya, J Kelly, G Corna, M Golino, A Abbate… - Molecules, 2023 - mdpi.com
Cannabidiol (CBD) is the primary non-psychoactive chemical from Cannabis Sativa, a plant
used for centuries for both recreational and medicinal purposes. CBD lacks the psychotropic …

The impact of marijuana on the cardiovascular system: a review of the most common cardiovascular events associated with marijuana use

Z Latif, N Garg - Journal of clinical medicine, 2020 - mdpi.com
With the expanded legalization of marijuana, its medical and recreational use have sharply
increased over the past decade. A wide array of new forms of cannabis is available on the …

[PDF][PDF] Goodman and Gilman's the pharmacological basis of therapeutics. Twelfth

L Brunton, BA Chabner, BC Knollmann - 2011 - iqcglobal.com
Alice gets the thread. Perhaps these books are longer than just a couple of ages. Again if
that and something else is easier it's more that in your life this is a fun read for you. When the …

THC and CBD: villain versus hero? Insights into adolescent exposure

N Pintori, F Caria, MA De Luca, C Miliano - International Journal of …, 2023 - mdpi.com
Cannabis is the most used drug of abuse worldwide. It is well established that the most
abundant phytocannabinoids in this plant are Δ9-tetrahydrocannabinol (THC) and …

[HTML][HTML] A focused review on CB2 receptor-selective pharmacological properties and therapeutic potential of β-caryophyllene, a dietary cannabinoid

HM Hashiesh, C Sharma, SN Goyal, B Sadek… - Biomedicine & …, 2021 - Elsevier
The endocannabinoid system (ECS), a conserved physiological system emerged as a novel
pharmacological target for its significant role and potential therapeutic benefits ranging from …

Medical cannabis use in Thailand after its legalization: a respondent-driven sample survey

S Assanangkornchai, K Thaikla, M Talek, D Saingam - PeerJ, 2022 - peerj.com
Background Many countries now allow the consumption of cannabis or cannabinoids for
medical purposes with varying approaches concerning products allowed and the regulatory …

[HTML][HTML] Polypharmacy in multiple sclerosis: current knowledge and future directions

J Thelen, V Zvonarev, S Lam, C Burkhardt… - Missouri …, 2021 - ncbi.nlm.nih.gov
Polypharmacy, or the daily use of five or more medications, is well documented in older
adults and linked to negative outcomes such as medication errors, adverse drug reactions …

Patients who have cannabis use disorder have higher rates of venous thromboemboli, readmission rates, and costs following primary total knee arthroplasty

RM Vakharia, N Sodhi, HK Anis, JO Ehiorobo… - The Journal of …, 2020 - Elsevier
Background Studies have shown that cannabis can interfere with hematological parameters
and platelet morphology. The purpose of this study is to investigate whether patients with …

Substance use and common contributors to morbidity: A genetics perspective

S Sanchez-Roige, RL Kember, A Agrawal - EBioMedicine, 2022 - thelancet.com
Excessive substance use and substance use disorders (SUDs) are common, serious and
relapsing medical conditions. They frequently co-occur with other diseases that are leading …

A review of cannabis allergy in the early days of legalization

A Toscano, DG Ebo, K Abbas, H Brucker… - Annals of Allergy …, 2023 - Elsevier
Cannabis allergy is a burgeoning field; consequently, research is still in its infancy and
allergists' knowledge surrounding this topic is limited. As cannabis legalization expands …